Our Services
Medical Information
Helpful Resources
Published on: 3/10/2026
There are several key signs and steps to consider if your child seems unusually weak, including the possibility of Duchenne muscular dystrophy, a progressive genetic muscle disorder that primarily affects boys ages 2 to 5; early clues include delayed walking, frequent falls, toe walking, difficulty standing up without using the hands, and large calves. See below for how these signs progress and what else to watch.
Act promptly by seeing a pediatrician, requesting a creatine kinase blood test and confirmatory genetic testing, and asking for referrals to neurology, cardiology, pulmonology, and physical therapy, since early care can protect muscle, heart, and breathing. For critical details on red flags that need urgent care and on treatment options that may change your next steps, see below.
It's normal for children to be clumsy, tire easily, or develop at different speeds. But if your child seems unusually weak, struggles to keep up with peers, or is losing skills they once had, it's important to pay attention.
One possible cause of progressive muscle weakness in boys is Duchenne muscular dystrophy (DMD) — a serious but manageable genetic condition. Early diagnosis can make a meaningful difference in care, treatment options, and long-term outcomes.
This guide explains what Duchenne muscular dystrophy is, the signs to watch for, and the medical steps to take if you're concerned.
Duchenne muscular dystrophy is a genetic disorder that causes progressive muscle weakness. It primarily affects boys and is usually diagnosed between ages 2 and 5.
DMD is caused by a mutation in the dystrophin gene. Dystrophin is a protein that helps protect and strengthen muscle cells. Without it, muscles gradually break down and are replaced by fat and scar tissue.
Over time, this affects:
DMD is considered one of the most common and severe forms of muscular dystrophy in children.
Symptoms often begin subtly. Many parents first notice that their child seems "behind" physically.
A classic sign of Duchenne muscular dystrophy is the Gowers' sign. This happens when a child uses their hands to push off their thighs to stand up from the floor because their hip and thigh muscles are weak.
Symptoms typically worsen over time because DMD is progressive.
While every child is different, the typical progression includes:
Modern treatments have significantly improved life expectancy and quality of life. With appropriate care, many individuals with DMD now live into their 30s or longer.
You should speak with a doctor if your child:
If you're noticing several of these warning signs and want to better understand whether they could be related to Muscular Dystrophy, a free AI-powered symptom checker can help you prepare specific questions and observations to discuss with your pediatrician.
However, an online tool is not a substitute for a medical evaluation.
If a doctor suspects Duchenne muscular dystrophy, they will usually begin with simple blood testing.
Children with DMD have very high levels of creatine kinase (CK), an enzyme released when muscle breaks down.
A blood test can confirm mutations in the dystrophin gene. This is the definitive diagnostic test.
Depending on the case:
Early genetic confirmation is critical because newer treatments target specific gene mutations.
While there is currently no cure for Duchenne muscular dystrophy, treatments have advanced significantly in recent years.
Care typically involves a multidisciplinary team including:
Corticosteroids (such as prednisone or deflazacort)
These can slow muscle degeneration and preserve strength longer.
Exon-skipping therapies
Designed for specific genetic mutations to help the body produce a shortened but functional dystrophin protein.
Cardiac medications
Help protect heart function.
Regular therapy helps:
As breathing muscles weaken, some individuals may require:
Early treatment improves long-term outcomes. This is why prompt evaluation matters.
Duchenne muscular dystrophy is inherited in an X-linked recessive pattern.
If DMD is diagnosed, a genetics specialist can discuss family planning options and testing for siblings.
No. But you should act.
Muscle weakness in children has many possible causes. Some are mild. Others, like Duchenne muscular dystrophy, require specialized care.
Early diagnosis allows:
Waiting does not make symptoms clearer — it delays care.
If you're concerned your child may be weak:
If your child is having:
Seek urgent medical care immediately.
Hearing the words "Duchenne muscular dystrophy" is overwhelming. It is a serious diagnosis. But it is also one where:
Families are not alone in navigating this condition.
If your child seems weak, especially with delayed walking, frequent falls, or difficulty getting up from the floor, it is important to evaluate the possibility of Duchenne muscular dystrophy.
DMD is a progressive genetic muscle disorder that:
Early testing — starting with a simple blood test — can provide answers quickly.
If you have any concern that your child's symptoms could be serious or life-threatening, speak to a doctor immediately. Prompt evaluation can change the course of care and improve long-term outcomes.
Trust your instincts. If something feels off, it's worth checking.
(References)
* Mendell JR, et al. Duchenne Muscular Dystrophy: A Review of Diagnosis and Management. JAMA. 2022 Sep 13;328(10):974-984. doi: 10.1001/jama.2022.14811. PMID: 36104443.
* Bertini E, et al. Duchenne muscular dystrophy in 2022. Lancet Neurol. 2022 Sep;21(9):839-851. doi: 10.1016/S1474-4422(22)00249-1. Epub 2022 Aug 4. PMID: 35928813.
* Birnkrant DJ, et al. The diagnosis and management of Duchenne muscular dystrophy: a revised and extended international standard of care. Lancet Neurol. 2018 Jul;17(7):589-605. doi: 10.1016/S1474-4422(18)30182-9. Epub 2018 May 11. PMID: 28701258.
* Guimarães-Mostarda NM, et al. Updates in the Management of Duchenne Muscular Dystrophy. Curr Treat Options Neurol. 2020 Oct 14;22(11):38. doi: 10.1007/s11940-020-00645-x. PMID: 32958745.
* Zuccarello D, et al. An Update on Duchenne Muscular Dystrophy: Pathogenesis, Diagnosis, and Treatment. Cells. 2021 Jun 24;10(7):1598. doi: 10.3390/cells10071598. PMID: 34213346; PMCID: PMC8304911.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.